{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T23:13:02Z","timestamp":1778109182454,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100010722","name":"Harbin Medical University","doi-asserted-by":"publisher","award":["HYDSYTB202234"],"award-info":[{"award-number":["HYDSYTB202234"]}],"id":[{"id":"10.13039\/100010722","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017661","name":"China Health Promotion Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jsbmb.2026.107017","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T16:25:12Z","timestamp":1775579112000},"page":"107017","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Canagliflozin alleviates hyperandrogen-induced granulosa cell ferroptosis in polycystic ovary syndrome mice by activating the AMPK\/GSK3\u03b2\/NRF2 pathway"],"prefix":"10.1016","volume":"261","author":[{"given":"Jindan","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weilun","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yilin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiyu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiqiao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanfei","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsbmb.2026.107017_bib1","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1007\/s00404-024-07607-x","article-title":"Global prevalence of polycystic ovary syndrome in women worldwide: a comprehensive systematic review and meta-analysis","volume":"310","author":"Salari","year":"2024","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.jsbmb.2026.107017_bib2","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S2213-8587(22)00163-2","article-title":"Polycystic ovary syndrome","volume":"10","author":"Joham","year":"2022","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.jsbmb.2026.107017_bib3","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/s41574-024-01057-w","article-title":"Polycystic ovary syndrome as a metabolic disease","volume":"21","author":"Helvaci","year":"2025","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.jsbmb.2026.107017_bib4","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12958-024-01337-0","article-title":"Oxidative stress and energy metabolism abnormalities in polycystic ovary syndrome: from mechanisms to therapeutic strategies","volume":"22","author":"Yan","year":"2024","journal-title":"Reprod. Biol. Endocrinol."},{"key":"10.1016\/j.jsbmb.2026.107017_bib5","doi-asserted-by":"crossref","first-page":"392","DOI":"10.3390\/antiox13040392","article-title":"Exploring the antioxidative effects of ginger and cinnamon: a comprehensive review of evidence and molecular mechanisms involved in Polycystic Ovary Syndrome (PCOS) and other oxidative stress-related disorders","volume":"13","author":"Novakovic","year":"2024","journal-title":"Antioxidants"},{"key":"10.1016\/j.jsbmb.2026.107017_bib6","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.freeradbiomed.2024.11.021","article-title":"Leonurine restrains granulosa cell ferroptosis through SLC7A11\/GPX4 axis to promote the treatment of polycystic ovary syndrome","volume":"226","author":"Huang","year":"2025","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.jsbmb.2026.107017_bib7","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/d41586-019-03145-8","article-title":"A powerful cell-protection system prevents cell death by ferroptosis","volume":"575","author":"Stockwell","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.jsbmb.2026.107017_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217697","article-title":"Glutathione metabolism in ferroptosis and cancer therapy","volume":"621","author":"Xue","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jsbmb.2026.107017_bib9","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/s41580-025-00843-2","article-title":"Recommendations for robust and reproducible research on ferroptosis","volume":"26","author":"Mishima","year":"2025","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jsbmb.2026.107017_bib10","doi-asserted-by":"crossref","DOI":"10.1093\/hropen\/hoae013","article-title":"Ovarian ferroptosis induced by androgen is involved in pathogenesis of PCOS","volume":"2024","author":"Li","year":"2024","journal-title":"Hum. Reprod. Open"},{"key":"10.1016\/j.jsbmb.2026.107017_bib11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41572-024-00511-3","article-title":"Polycystic ovary syndrome","volume":"10","author":"Stener-Victorin","year":"2024","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.jsbmb.2026.107017_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.830401","article-title":"A meta-analysis of the effect of sodium glucose cotransporter-2 inhibitors on metabolic parameters in patients with polycystic ovary syndrome","volume":"13","author":"Sinha","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.jsbmb.2026.107017_bib13","article-title":"Canagliflozin combined with metformin versus metformin monotherapy for endocrine and metabolic profiles in overweight and obese women with polycystic ovary syndrome: a single-center, open-labeled prospective randomized controlled trial","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.jsbmb.2026.107017_bib14","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/dom.14583","article-title":"Efficacy of canagliflozin versus metformin in women with polycystic ovary syndrome: a randomized, open-label, noninferiority trial","volume":"24","author":"Cai","year":"2022","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.jsbmb.2026.107017_bib15","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1038\/s41401-022-01031-0","article-title":"SGLT2 inhibitor empagliflozin promotes revascularization in diabetic mouse hindlimb ischemia by inhibiting ferroptosis","volume":"44","author":"Han","year":"2023","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.jsbmb.2026.107017_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.121207","article-title":"Empagliflozin attenuates trastuzumab-induced cardiotoxicity through suppression of DNA damage and ferroptosis","volume":"312","author":"Min","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.jsbmb.2026.107017_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.177207","article-title":"Empagliflozin promotes skin flap survival by activating AMPK signaling pathway","volume":"987","author":"Yang","year":"2025","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.jsbmb.2026.107017_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155423","article-title":"Baicalein improves the symptoms of polycystic ovary syndrome by mitigating oxidative stress and ferroptosis in the ovary and gravid placenta","volume":"128","author":"Li","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jsbmb.2026.107017_bib19","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1080\/15548627.2022.2094671","article-title":"Epg5 deficiency leads to primary ovarian insufficiency due to WT1 accumulation in mouse granulosa cells","volume":"19","author":"Liu","year":"2023","journal-title":"Autophagy"},{"key":"10.1016\/j.jsbmb.2026.107017_bib20","doi-asserted-by":"crossref","DOI":"10.1126\/science.adk5382","article-title":"Artemisinins ameliorate polycystic ovarian syndrome by mediating LONP1-CYP11A1 interaction","volume":"384","author":"Liu","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.jsbmb.2026.107017_bib21","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1095\/biolreprod.114.120063","article-title":"High-fat diet induces significant metabolic disorders in a mouse model of polycystic ovary syndrome","volume":"91","author":"Lai","year":"2014","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.jsbmb.2026.107017_bib22","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.2147\/DDDT.S388823","article-title":"Canagliflozin attenuates hepatic steatosis and atherosclerosis progression in western diet-Fed ApoE-knockout mice","volume":"16","author":"Zuo","year":"2022","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.jsbmb.2026.107017_bib23","doi-asserted-by":"crossref","first-page":"4084","DOI":"10.1038\/s41467-020-17915-w","article-title":"Scavenging of reactive dicarbonyls with 2-hydroxybenzylamine reduces atherosclerosis in hypercholesterolemic Ldlr(-\/-) mice","volume":"11","author":"Tao","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jsbmb.2026.107017_bib24","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.2337\/db16-0058","article-title":"The Na+\/glucose cotransporter inhibitor canagliflozin activates AMPK by inhibiting mitochondrial function and increasing cellular AMP levels","volume":"65","author":"Hawley","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.jsbmb.2026.107017_bib25","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/s41420-021-00726-3","article-title":"GSK-3beta manipulates ferroptosis sensitivity by dominating iron homeostasis","volume":"7","author":"Wang","year":"2021","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.jsbmb.2026.107017_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101107","article-title":"NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis","volume":"23","author":"Dodson","year":"2019","journal-title":"Redox Biol."},{"key":"10.1016\/j.jsbmb.2026.107017_bib27","doi-asserted-by":"crossref","DOI":"10.4028\/b-wjQRP6","article-title":"A NRF2 regulated and the immunosuppressive microenvironment reversed nanoplatform for cholangiocarcinoma photodynamic-gas therapy","volume":"11","author":"Wang","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jsbmb.2026.107017_bib28","doi-asserted-by":"crossref","first-page":"38","DOI":"10.20892\/j.issn.2095-3941.2018.0253","article-title":"The PI3K\/Akt\/GSK-3beta\/ROS\/eIF2B pathway promotes breast cancer growth and metastasis via suppression of NK cell cytotoxicity and tumor cell susceptibility","volume":"16","author":"Jin","year":"2019","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.jsbmb.2026.107017_bib29","doi-asserted-by":"crossref","first-page":"932","DOI":"10.4239\/wjd.v12.i7.932","article-title":"Exploring new treatment options for polycystic ovary syndrome: review of a novel antidiabetic agent SGLT2 inhibitor","volume":"12","author":"Marinkovic-Radosevic","year":"2021","journal-title":"World J. Diabetes"},{"key":"10.1016\/j.jsbmb.2026.107017_bib30","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3682","article-title":"Cardiometabolic effects of SGLT2 inhibitors on polycystic ovary syndrome","volume":"39","author":"Lempesis","year":"2023","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.jsbmb.2026.107017_bib31","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/s41392-022-01073-0","article-title":"Trends in insulin resistance: insights into mechanisms and therapeutic strategy","volume":"7","author":"Li","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.jsbmb.2026.107017_bib32","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/S0140-6736(15)60331-2","article-title":"Effect of insulin on AKR1C3 expression in female adipose tissue: in-vivo and in-vitro study of adipose androgen generation in polycystic ovary syndrome","volume":"385","author":"O'Reilly","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jsbmb.2026.107017_bib33","article-title":"Broadening horizons: the role of ferroptosis in polycystic ovary syndrome","volume":"15","author":"Wang","year":"2024","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.jsbmb.2026.107017_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115415","article-title":"The emerging role of ferroptosis in female reproductive disorders","volume":"166","author":"Liu","year":"2023","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.jsbmb.2026.107017_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2026.104034","article-title":"Methylation reader MBD2-mediated GPX4 transcriptional repression drives ovarian granulosa cell ferroptosis in PCOS","volume":"90","author":"Zhu","year":"2026","journal-title":"Redox Biol."},{"key":"10.1016\/j.jsbmb.2026.107017_bib36","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.molmet.2016.08.014","article-title":"The diabetes medication Canagliflozin reduces cancer cell proliferation by inhibiting mitochondrial complex-I supported respiration","volume":"5","author":"Villani","year":"2016","journal-title":"Mol. Metab."},{"key":"10.1016\/j.jsbmb.2026.107017_bib37","doi-asserted-by":"crossref","first-page":"858","DOI":"10.3390\/ijms24010858","article-title":"Canagliflozin attenuates lipotoxicity in cardiomyocytes by inhibiting inflammation and ferroptosis through activating AMPK pathway","volume":"24","author":"Zhang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jsbmb.2026.107017_bib38","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3390\/antiox14050615","article-title":"Sex-specific antioxidant and anti-inflammatory protective effects of AMPK in cardiovascular diseases","volume":"14","author":"Strohm","year":"2025","journal-title":"Antioxidants"}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096007602600083X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096007602600083X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T22:26:21Z","timestamp":1778106381000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096007602600083X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":38,"alternative-id":["S096007602600083X"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2026.107017","relation":{},"ISSN":["0960-0760"],"issn-type":[{"value":"0960-0760","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Canagliflozin alleviates hyperandrogen-induced granulosa cell ferroptosis in polycystic ovary syndrome mice by activating the AMPK\/GSK3\u03b2\/NRF2 pathway","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2026.107017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107017"}}